RT Book, Section
A1 Iglesias, David A.
A1 Huang, Marilyn
A1 Soliman, Pamela T.
A1 Djordjevic, Bojana
A1 Lu, Karen H.
A2 Karlan, Beth Y.
A2 Bristow, Robert E.
A2 Li, Andrew J.
SR Print(0)
ID 1106570250
T1 Endometrial Hyperplasia and Cancer
T2 Gynecologic Oncology: Clinical Practice and Surgical Atlas
YR 2015
FD 2015
PB McGraw-Hill Medical
PP New York, NY
SN 9780071749268
LK obgyn.mhmedical.com/content.aspx?aid=1106570250
RD 2024/04/20
AB Endometrial  cancer  is  the  most  common  malignancy  of  the  female  genital  tract  in  the  United  States.  Women  have  an  overall  lifetime  risk  of  2.5%  of  developing  endometrial  cancer.  Fortunately,  the  majority  of  endometrial  present  at  early  stages  with  postmenopausal  bleeding.  Although  obesity  and  estrogen  excess  remain  the  strongest  risk  factors  for  this  disease,  Lynch  syndrome  comprises  the  majority  of  inherited  endometrial  cancer  cases;  affected  women  have  a  40%  to  60%  predicted  lifetime  risk  of  developing  endometrial  cancer.